Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells
about
The Life-Cycle of the HIV-1 Gag-RNA ComplexEvolution of a species-specific determinant within human CRM1 that regulates the post-transcriptional phases of HIV-1 replicationContribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in miceSRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNAAdaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.Capsid is a dominant determinant of retrovirus infectivity in nondividing cells.The Mason-Pfizer monkey virus internal scaffold domain enables in vitro assembly of human immunodeficiency virus type 1 Gag.Human chromosome 2 carries a gene required for production of infectious human immunodeficiency virus type 1.Replacement of murine leukemia virus readthrough mechanism by human immunodeficiency virus frameshift allows synthesis of viral proteins and virus replication.Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells.Molecular determinants that regulate plasma membrane association of HIV-1 GagCell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular bodyRetroviral mRNA nuclear export elements regulate protein function and virion assembly.Isolation and characterization of mouse-human microcell hybrid cell clones permissive for infectious HIV particle release.Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles.Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells.Capsid is an important determinant for functional complementation of murine leukemia virus and spleen necrosis virus Gag proteinsAnalysis of human immunodeficiency virus matrix domain replacements.Murine T cells potently restrict human immunodeficiency virus infection.Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.Retroviral matrix and lipids, the intimate interaction.Disparate Contributions of Human Retrovirus Capsid Subdomains to Gag-Gag Oligomerization, Virus Morphology, and Particle Biogenesis.Effect of multimerization on membrane association of Rous sarcoma virus and HIV-1 matrix domain proteins.A new retroelement constituted by a natural alternatively spliced RNA of murine replication-competent retroviruses.Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays.Matrix-induced inhibition of membrane binding contributes to human immunodeficiency virus type 1 particle assembly defects in murine cells.Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells.Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix.HIV-1 Vif's capacity to manipulate the cell cycle is species-specific.
P2860
Q28076985-C70C82CE-000B-4A39-82C9-A867296C5723Q28742565-C189A902-2D7E-4429-B6F1-F37754A2E8C4Q33717736-1C1A7AE2-886F-49D4-871D-081938EBF7EDQ33990712-474EE6AF-A269-46B6-A0A0-D7C24BF22F03Q34124490-DDAA6BC1-820E-47CD-ACDB-9F46E4BE3D2AQ34152408-6D011932-A202-4536-A9C2-3B3A0A8A9484Q34350076-5E871412-3F0C-4ACD-8808-138AE68020B3Q34545610-176A3F95-E73E-4F47-8C9B-7CD6BE287BAAQ34757472-765474B2-4D61-4DDB-8FE1-1172DC667A72Q34987465-0213672E-6D7A-43C0-8B52-70EB533B6EF7Q35113734-8DD4490A-11A9-467D-8EE4-1E609F7453E7Q35543719-78904609-93CC-48CA-820B-6CA2CA7C0173Q35836276-A63D57F6-5D33-4544-8B82-00E15A251E27Q36005484-922EFFC3-25AC-4ECB-82F9-4CE25D8403CFQ36010016-06DBD55C-851C-48BA-9ECC-6F4447EAD621Q36571363-A501BD57-6068-4BCD-A681-5DBAB29C6FE5Q37252303-67D05F84-3484-474E-8B23-45AAC1637C40Q37255552-FA3C0665-F77A-4AB1-AECE-4041AEC81DD2Q37596977-C030A9D2-F257-4319-8B74-BD0A667D5423Q37746426-07BF8915-E68B-4B32-9C56-C38EFF53F031Q37850839-260B8DB1-0D2A-4192-8725-746FBCA51236Q38705926-D7B9920B-8D74-44E7-A944-35DB355CD42AQ39083964-A6D50D63-C203-4CE7-8E0D-3FFCF6C06A99Q39958715-3107D2B6-AC29-451A-BCA9-759A784D75B8Q40096523-321B06DA-F162-4B83-BC58-4BE405030D05Q40670620-6D5CC0FC-B346-45AF-85A9-FB69B8F3FC37Q42800068-551C1EE8-1400-425F-8225-E90C8C35FE6CQ42947265-549590E0-5D2E-4E54-9E6E-332F6CF8C7DBQ47555826-2D55BE6E-BB4E-4CDA-A202-B2BC584E7FB3
P2860
Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells
@ast
Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells
@en
type
label
Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells
@ast
Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells
@en
prefLabel
Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells
@ast
Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells
@en
P2093
P2860
P356
P1476
Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells
@en
P2093
P2860
P304
15239-15244
P356
10.1073/PNAS.261563198
P407
P577
2001-12-11T00:00:00Z